ALENTIS Therapeutics launches, raising CHF 12.5m in a Series A to develop novel therapeutics in advanced liver disease and cancer

Press/Media

Period	24 May 2019

Media coverage

Title	ALENTIS Therapeutics launches, raising CHF 12.5m in a Series A to develop novel therapeutics in advanced liver disease and cancer
Media name/outlet	High-Tech Gründerfonds GmbH
Country/Territory	Germany
Date	24/05/19
URL	https://high-tech-gruenderfonds.de/en/alentis-therapeutics-launches-raising-chf-12-5m-in-a-series-a-to-develop-novel-therapeutics-in-advanced-liver-disease-and-cancer/
Persons	Yujin Hoshida